
WORX Valuation
Scworx Corp
- Overview
- Forecast
- Valuation
- Earnings
WORX Relative Valuation
WORX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, WORX is overvalued; if below, it's undervalued.
Historical Valuation
Scworx Corp (WORX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Scworx Corp (WORX) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.35
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Scworx Corp. (WORX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Scworx Corp. (WORX) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Scworx Corp. (WORX) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Scworx Corp. (WORX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Scworx Corp. (WORX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Scworx Corp (WORX) has a current Price-to-Book (P/B) ratio of 0.41. Compared to its 3-year average P/B ratio of 0.59 , the current P/B ratio is approximately -31.13% higher. Relative to its 5-year average P/B ratio of 1.48, the current P/B ratio is about -72.30% higher. Scworx Corp (WORX) has a Forward Free Cash Flow (FCF) yield of approximately -68.83%. Compared to its 3-year average FCF yield of -40.01%, the current FCF yield is approximately 72.02% lower. Relative to its 5-year average FCF yield of -26.66% , the current FCF yield is about 158.18% lower.
0.41
P/B
Median3y
0.59
Median5y
1.48
-65.80
FCF Yield
Median3y
-40.01
Median5y
-26.66
Competitors Valuation Multiple
The average P/S ratio for WORX's competitors is 3.60, providing a benchmark for relative valuation. Scworx Corp Corp (WORX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -8.00%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of WORX decreased by 71.31% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -45.46 to -279.23.
The secondary factor is the Revenue Growth, contributed -8.00%to the performance.
Overall, the performance of WORX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

TNFA
TNF Pharmaceuticals Inc
0.048
USD
-21.10%

STSS
Sharps Technology Inc
13.550
USD
-15.47%

SOPA
Society Pass Inc
1.340
USD
-0.74%

FAMI
Farmmi Inc
1.690
USD
-3.43%

PTIX
Protagenic Therapeutics Inc
3.600
USD
+1.41%

NDRA
ENDRA Life Sciences Inc
4.088
USD
-1.26%

BENF
Beneficient
0.405
USD
+6.58%

TC
Token Cat Ltd
13.130
USD
+6.73%

RSLS
ReShape Lifesciences Inc
0
USD
+18.37%
FAQ

Is Scworx Corp (WORX) currently overvalued or undervalued?
Scworx Corp (WORX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Scworx Corp (WORX) is between to according to relative valuation methord.

What is Scworx Corp (WORX) fair value?

How does WORX's valuation metrics compare to the industry average?

What is the current P/B ratio for Scworx Corp (WORX) as of Aug 30 2025?

What is the current FCF Yield for Scworx Corp (WORX) as of Aug 30 2025?

What is the current Forward P/E ratio for Scworx Corp (WORX) as of Aug 30 2025?
